Delivery Order SPE2DB20D2002-SPE2DB23FL66S
Award Date 9/5/23
Potential Completion Date 9/6/23
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.59 firm fixed-price delivery order is for the supply of 4,562,698,218 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a completion date of November 6, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.04 firm fixed-price delivery order is for the supply of 4,567,752,489 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,141.71, is for the delivery of 4,563,619,057 units of the prescription drug Pantoprazole Sodium Delayed Release 40 mg Tablets in quantities of 1,000. The contract has a firm fixed price and an ultimate completion date of February 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $5,637.03, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4,564,977,390 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a completion date of June 24, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,038.98 Firm Fixed Price Delivery Order is for the supply of 4,563,401,913 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,560,733 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000 count bottles. The $5,544.87 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQE54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,132.94, is for the delivery of 4,564,451,658 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets 1000s. This is a Firm Fixed Price delivery order contract with a completion date of May 1, 2024. The contract does not have a set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $2,663.15 for the provision of 4,567,828,723 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,032.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides Pantoprazole Sodium Delayed-Release 20 mg Tablets in quantities of 90s. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...